rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Mark E. Bunnage

EVP, Chief Scientific Officer

Company insider

Files Form 4 as: EVP, Chief Scientific Officer, Vertex Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
20
Buys
0
Sells
5
Bought
$0
Sold
$6.0M
Companies
1
Companies where not an officer
0
First trade
10 Feb 2026
Last trade
15 May 2026
Last filed
19 May 2026

Companies traded

Where they are an officer
VRTX Vertex PharmaceuticalsOfficer · Biotechnology · last 15 May 20260 buys · 5 sells

Activity over time

1 Feb – 1 Oct
40Feb 26Apr 26Jun 26Aug 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 May 2026filed 19 May 2026VRTX Vertex PharmaceuticalsBiotechnologySEC FORM 4 Sold$15K33 at $453.45filing
15 May 2026filed 19 May 2026VRTX Vertex PharmaceuticalsBiotechnologySEC FORM 4 Sold$15K33 at $453.45filing
25 Feb 2026filed 26 Feb 2026VRTX Vertex PharmaceuticalsBiotechnologySEC FORM 4 Sold$302K620 at $486.35filing
25 Feb 2026filed 26 Feb 2026VRTX Vertex PharmaceuticalsBiotechnologySEC FORM 4 Sold$302K620 at $486.35filing
24 Feb 2026filed 26 Feb 2026VRTX Vertex PharmaceuticalsBiotechnologySEC FORM 4 Code F$282K582 at $485.11filing
24 Feb 2026filed 26 Feb 2026VRTX Vertex PharmaceuticalsBiotechnologySEC FORM 4 Code F$282K582 at $485.11filing
18 Feb 2026filed 19 Feb 2026VRTX Vertex PharmaceuticalsBiotechnologySEC FORM 4 Sold$560K1,182 at $473.68filing
18 Feb 2026filed 19 Feb 2026VRTX Vertex PharmaceuticalsBiotechnologySEC FORM 4 Sold$560K1,182 at $473.68filing
17 Feb 2026filed 19 Feb 2026VRTX Vertex PharmaceuticalsBiotechnologySEC FORM 4 Code A—2,584 at $0.00filing
17 Feb 2026filed 19 Feb 2026VRTX Vertex PharmaceuticalsBiotechnologySEC FORM 4 Code F$537K1,110 at $483.75filing
17 Feb 2026filed 19 Feb 2026VRTX Vertex PharmaceuticalsBiotechnologySEC FORM 4 Sold$1.2M2,437 at $489.46filing
17 Feb 2026filed 19 Feb 2026VRTX Vertex PharmaceuticalsBiotechnologySEC FORM 4 Code A—2,584 at $0.00filing
17 Feb 2026filed 19 Feb 2026VRTX Vertex PharmaceuticalsBiotechnologySEC FORM 4 Code F$537K1,110 at $483.75filing
17 Feb 2026filed 19 Feb 2026VRTX Vertex PharmaceuticalsBiotechnologySEC FORM 4 Sold$1.2M2,437 at $489.46filing
13 Feb 2026filed 18 Feb 2026VRTX Vertex PharmaceuticalsBiotechnologySEC FORM 4 Code F$1.1M2,283 at $487.76filing
13 Feb 2026filed 18 Feb 2026VRTX Vertex PharmaceuticalsBiotechnologySEC FORM 4 Code F$1.1M2,283 at $487.76filing
11 Feb 2026filed 12 Feb 2026VRTX Vertex PharmaceuticalsBiotechnologySEC FORM 4 Sold$931K2,021 at $460.43filing
11 Feb 2026filed 12 Feb 2026VRTX Vertex PharmaceuticalsBiotechnologySEC FORM 4 Sold$931K2,021 at $460.43filing
10 Feb 2026filed 12 Feb 2026VRTX Vertex PharmaceuticalsBiotechnologySEC FORM 4 Code F$528K1,127 at $468.41filing
10 Feb 2026filed 12 Feb 2026VRTX Vertex PharmaceuticalsBiotechnologySEC FORM 4 Code F$528K1,127 at $468.41filing

Sectors

Health Care5

Buys in green, sells in red, by the company’s sector.

Related people

Alan M. GarberDirector · Director at Vertex Pharmaceuticals Inc / Ma, filing Form 4 there in the last year
Bruce I. SachsDirector · Director at Vertex Pharmaceuticals Inc / Ma, filing Form 4 there in the last year
Jasper van GrunsvenEVP, CP and NPPO · EVP, CP and NPPO at Vertex Pharmaceuticals Inc / Ma, filing Form 4 there in the last year
Kristen AmbroseSVP & Chief Accounting Officer · SVP & Chief Accounting Officer at Vertex Pharmaceuticals Inc / Ma, filing Form 4 there in the last year
Amit SachdevEVP Chief Patient & Ext Af Off · EVP Chief Patient & Ext Af Off at Vertex Pharmaceuticals Inc / Ma, filing Form 4 there in the last year
David J. TaylorRepresentative, OH-02 · Also traded VRTX in the last 90 days
Donald J. TrumpPresident · Also traded VRTX in the last 90 days